Cynthia L. Schwalm's most recent trade in G1 Therapeutics Inc was a trade of 19,620 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
G1 Therapeutics Inc | Cynthia L. Schwalm | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 19,620 | 19,620 | - | - | Stock Options (Right to Buy) | |
G1 Therapeutics Inc | Cynthia L. Schwalm | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 4,389 | 5,889 (0%) | 0% | 0 | Common Stock | |
Lisata Therapeutics Inc | Cynthia L. Schwalm | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 37,735 | 80,417 (0%) | 0% | 0 | Common Stock | |
G1 Therapeutics Inc | Cynthia L. Schwalm | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) |